UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)
UvA-DARE (Digital Academic Repository)
Metformin in polycystic ovary syndrome
Moll, E.
Publication date
2013
Link to publication
Citation for published version (APA):
Moll, E. (2013). Metformin in polycystic ovary syndrome.
General rights
It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).
Disclaimer/Complaints regulations
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.
86
Table III. Pregnancy rates for combined subgroups in women with PCOS treated with
clomifene citrate plus metformin or clomifene citrate alone.
N metformin n/N (%) placebo n/N (%) RR (95% CI) p-value Age (years) < 28, WHR < 0.85 54 10/32 (31) 13/22 (59) 0.53 (0.28-0.98) 0.014 Age (years) ≥ 28, WHR < 0.85 80 23/38 (61) 24/42 (57) 1.1 (0.73-1.5) Age (years) < 28, WHR ≥ 0.85 29 3/14 (21) 5/15 (33) 0.64 (0.19-2.2) Age (years) ≥ 28, WHR ≥ 0.85 42 7/18 (39) 6/24 (25) 1.6 (0.98-3.8)
Figure 1. Relative Risks and 95% confidence intervals for combined subgroups of
women treated with clomifene citrate plus metformin or clomifene citrate alone with respect to pregnancy rates.
Age ≥ 28 WHR < 0.85 Age < 28 WHR < 0.85 Age ≥ 28 WHR ≥ 0.85 Age < 28 WHR ≥ 0.85